La Jolla, CA, United States of America

Wilfried Roth


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Wilfried Roth

Introduction

Wilfried Roth is a notable inventor based in La Jolla, California. He has made significant contributions to the field of molecular biology, particularly in the area of death domain proteins. His work has implications for drug discovery and the treatment of various diseases.

Latest Patents

Wilfried Roth holds a patent related to Death Domain (DD), Death Effector Domain (DED), and NB-ARC domain proteins. This invention provides novel proteins and nucleic acid molecules encoding these proteins. Additionally, it includes vectors containing these nucleic acid molecules and host cells that incorporate the vectors. The invention also encompasses antibodies that specifically bind to DDs, DEDs, or NB-ARC domains. These innovations are useful for discovering drugs that can suppress infections, autoimmunity, inflammation, allergies, allograft rejection, sepsis, and other diseases.

Career Highlights

Roth is associated with the Burnham Institute, where he has been able to further his research and development efforts. His work has been instrumental in advancing our understanding of molecular interactions and their potential therapeutic applications.

Collaborations

Some of his notable coworkers include John C. Reed and Adam Godzik. Their collaborative efforts have contributed to the success of various research projects and innovations in the field.

Conclusion

Wilfried Roth's contributions to the field of molecular biology through his patent on death domain proteins highlight the importance of innovation in medical research. His work continues to pave the way for advancements in drug discovery and treatment options for various diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…